Development of a core measurement set for research in degenerative cervical myelopathy: a study protocol (AO Spine RECODE-DCM CMS)

BMJ Open, 2022 · DOI: 10.1136/bmjopen-2021-060436 · Published: April 1, 2022

Spinal Cord Injury Neurology Rehabilitation

Simple Explanation

This research aims to create a standardized set of measurements for Degenerative Cervical Myelopathy (DCM) research. The core measurement set (CMS) will improve data consistency and accelerate improvements in outcomes for individuals with DCM. The CMS will be developed through a five-phase process involving systematic reviews, expert consensus, and implementation guidance.

Study Duration

Not specified

Participants

Multi-disciplinary panel of experts including people with lived experience and healthcare professionals.

Evidence Level

Not specified

Key Findings

1
The study has completed Phase 1, agreeing on measurement constructs and preferred measurement approaches.
2
Systematic reviews have identified clinically interpretable instruments, but gaps remain where no appropriate instruments exist.
3
Targeted scoping reviews will be performed to identify instruments used outside of DCM for these gap elements.

Research Summary

This protocol outlines the process for developing a CMS for DCM, based on the CDE and COS already defined by AO Spine RECODE-DCM. The CMS will focus on measurement instruments currently in usage to ensure immediate implementation in clinical practice and research studies. The CMS will be selected using modified nominal group techniques to ensure that all relevant perspectives are captured and appropriately represented in the decisions taken.

Practical Implications

Improved Data Comparability

The CMS will enable more consistent data measurement and reporting across DCM studies, facilitating between-study comparisons and evidence synthesis.

Accelerated Knowledge Discovery

By standardizing outcome measurements, the CMS will accelerate knowledge discovery and improve outcomes for people affected by DCM.

Enhanced Clinical Practice

The CMS will provide clinicians with a practical toolkit for assessing DCM, leading to more comprehensive and standardized patient care.

Study Limitations

1
The CMS will focus on measurement instruments currently in use and exclude instruments under development.
2
The CMS excludes instruments published in languages other than English.
3
There is a possibility for invalid instruments to be selected due to the inclusion of shortlisted instruments used in populations other than DCM.

Your Feedback

Was this summary helpful?

Back to Spinal Cord Injury

Development of a core measurement set for research in degenerative cervical myelopathy: a study protocol (AO Spine RECODE-­DCM CMS)

Simple Explanation

Key Findings

Research Summary

Practical Implications

Improved Data Comparability

Accelerated Knowledge Discovery

Enhanced Clinical Practice

Study Limitations

Your Feedback

Was this summary helpful?

Development of a core measurement set for research in degenerative cervical myelopathy: a study protocol (AO Spine RECODE-­DCM CMS)

Simple Explanation

Key Findings

Research Summary

Practical Implications

Improved Data Comparability

Accelerated Knowledge Discovery

Enhanced Clinical Practice

Study Limitations

Your Feedback

Was this summary helpful?

Development of a core measurement set for research in degenerative cervical myelopathy: a study protocol (AO Spine RECODE-DCM CMS)

Development of a core measurement set for research in degenerative cervical myelopathy: a study protocol (AO Spine RECODE-DCM CMS)